Excessive amounts of vascular endothelial growth factor (VEGF) is a major pathological change in wet AMD, and anti-VEGF can relieve or delay the progress of wet AMD (Xu et al., 2015; Wang et al., 2016). This evidence concerns the gene VEGFA and wet macular degeneration.